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BACKGROUND: Patients facing decisions should be
told about their options, have the opportunity to
discuss the pros and cons, and have their preferences
reflected in the final decision.
OBJECTIVES: To learn how decisions were made for
two major preference-sensitive interventions.
DESIGN: Mail survey of probability samples of patients
who underwent the procedures.
PARTICIPANTS: Fee-for-service Medicare beneficiaries
who had surgery for prostate cancer or elective coronary
artery stenting in the last half of 2008.
MAIN MEASUREMENTS: Patients’ reports of which
options were presented for serious consideration, the
amount of discussion of the pros and cons of the chosen
option, and if they were asked about their preferences.
RESULTS: The majority (64%) of prostate cancer
surgery patients reported that at least one alternative
to surgery was presented as a serious option. Almost all
(94%) said they and their doctors discussed the pros,
and 63% said they discussed the cons of surgery “a lot”
or “some”. Most (76%) said they were asked about their
treatment preferences. Few who received stents said
they were presented with options to seriously consider
(10%). While most (77%) reported talking with doctors
about the reasons for stents “a lot” or “some”, few (19%)
reported talking about the cons. Only 16% said they
were asked about their treatment preferences.
CONCLUSIONS: While prostate cancer surgery patients
reported more involvement in decision making than
elective stent patients, the reports of both groups docu-
ment the need for increased efforts to inform and involve
patients facing preference-sensitive intervention decisions.
KEY WORDS: shared decision making; decision quality; patient-
centered care.
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I n 1982, the President’s Commission for the Study ofEthical Problems in Medicine stated: “Patients who have
the capacity to make decisions about their care must be
permitted to do so voluntarily and must have all relevant
information regarding their condition and alternative
treatments, including possible benefits, risks, costs, other
consequences, and significant uncertainties around any of
this information.”1 In 2010, an American Medical
Association report states that when there is more than
one clinically appropriate course of treatment, the AMA
believes shared decision-making, including the use of
patient decision aids, has the potential to enhance the
overall value of health care in the United States.2 In the
30 years in between, many have articulated similar
standards for how medical decisions should be made.3–5
A recent development in thinking about the quality of
care is the patient-centered medical home (PCMH). The
American College of Physicians and the American
Academy of Family Practice have joined their pediatric
and osteopathic counterparts to endorse PCMH as a
standard of care. Among its tenets are that patients should
have a personal physician who ensures that “care is
coordinated and/or integrated across all elements of the
complex health care system” and that their patients have
the opportunity to participate in shared decision making
when faced with medical choices.6
Both prostate surgery for cancer and the elective insertion
of stents to treat coronary artery disease are prototypical
preference-sensitive interventions. External beam radiation,
brachytherapy and conservative management without im-
mediate treatment are all options for most prostate cancer
patients. Surgery may offer a slight survival advantage over
the alternatives but the serious side effects clearly make this a
decision in which patients should play an important role.7–10
Two recently published analyses indicate there is no survival
value of surgery for men over 6511 or for men with low-risk
cancers.12 Percutaneous coronary interventions (PCIs), most
commonly insertion of stents, have been shown to provide a
survival benefit if they are done within 24 hours of a
myocardial infarction (MI).13 However, most other patients
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with heart disease do not derive survival benefit over
medical management alone.14–17 Stenting can provide
angina relief, but similar benefits can be achieved with
medical management.17,18 Thus, both interventions, while
quite different clinically, are ideal for studying decision
making because they have small, if any, mortality benefits
over conservative management, potentially significant
quality of life implications and no clinical urgency: just
the kind of decisions for which informing and involving
patients is most important and for which medical homes
should be helpful.
A recent survey of Medicare beneficiaries who had
undergone either surgery for prostate cancer or elective
coronary artery stenting provides an opportunity to examine




A mail survey was conducted of Medicare beneficiaries
whose claims indicated they had either surgery for prostate
cancer of elective coronary artery stenting in the last half
of 2008. The study was approved by the Institutional
Review Boards of the Dartmouth Medical School and the
University of Massachusetts Boston and performed in
cooperation with the Centers for Medicare and Medicaid
Services (CMS).
Study Samples
Participants had to be enrolled in Medicare Parts A and B
with no managed care participation for the previous
12 months and had to be at least 66 years old at the time
of the procedure to allow at least one year to check prior
claims. Nursing home residents were excluded. Claims-
based algorithms were applied to identify potential
subjects for the period August 1, 2008 through December
31, 2008. A random sample of 800 patients who had
undergone each procedure was selected and sent to CMS,
which removed deceased individuals and returned contact
information for the rest.
Prostate surgery patients were eligible if they had an
inpatient claim for the procedure and evidence of a
prostate cancer diagnosis during the admission when the
prostatectomy was performed. Stent patients were eligible
if they had a Part B physician's claim for a stent procedure
or had a hospitalization during which there was an ICD-9
procedure code for a percutaneous coronary intervention
(PCI). They were excluded if they were admitted through
the emergency department, had either an acute myocardial
infarction ( AMI) or an unstable angina code associated
with the sampled claim, or had a claim for a PCI or
coronary artery bypass during the year preceding the
sampled procedure.
Questionnaire Development
The questions drew heavily on three previous surveys: two
surveys of prostate cancer patients9,10 and the 2008
DECISIONS survey about how nine decisions were
made.19,20 Cognitive testing was done to make sure most
respondents understood the questions and that their answers
accurately reflected what they had to say.21
Four survey questions are the focus of this analysis:
1. Before this (INTERVENTION), did a doctor talk with
you about (EACH ALTERNATIVE)?
1a. IF YES, Did the doctor talk about (EACH
ALTERNATIVE) as a choice to seriously consider?
Alternatives to prostate surgery were external beam
radiation, radioactive seed implants, and not having
active treatment right away. The alternatives to
stents were CABG and using medicine only.
2. Before the (INTERVENTION) how much did a doctor
talk with you about the reasons to have (INTERVEN-
TION)— a lot, some, a little, or not at all?
3. Before the (INTERVENTION), how much did a doctor
talk with you about why you might not want to have
(INTERVENTION)—a lot, some, a little, not at all?
4. Before this (INTERVENTION) did a doctor ask you if
you wanted to have (INTERVENTION) instead of
doing something else to manage your (CONDITION)?
Data Collection Protocols
Selected subjects were first sent a letter signed by the CMS
Privacy Officer describing the study and providing a toll-
free number to call to opt out. Two weeks later, subjects
who had not called were sent a cover letter, a questionnaire,
a postage paid return envelope, and a $5.00 cash incentive.
This was followed by a postcard reminder, another mailing
of the complete packet, and a reminder telephone call for
those for whom we could find a number. All respondent
contact materials were offered in both English and
Spanish.
Analysis
The coded answers were entered into a data file, then 100%
key verified.
To focus on decision making for people likely to have a
real choice, in our sampling we attempted to exclude those
who had an MI proximate to the stent procedure or who had
been admitted through an Emergency Room (ER). There
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were 23 survey respondents who said they had had a heart
attack within a week of the procedure and an additional 98
patients reported that they had been admitted through the
ER. These 121 patients were excluded so those analyzed
matched those whom studies show on average derive no
survival benefit from stents.
The answers to the four questions listed above were used
to create a Decision Process Score, giving one point each if
the respondent said providers 1) presented at least one
alternative to the intervention they received as something to
seriously consider, talked about the reasons 2) “for” and 3)
reasons “might not want” the intervention “a lot” or “some”
and 4) asked what the respondent wanted, yielding a score
ranging from zero to four.
There were 21 prostate cancer and 25 stent patients who
had three or four values missing from their Decisions
Scores, and they are omitted from the analysis. There were
79 (48 prostate cancer and 31 stent) respondents who had
one missing value and five who had two missing values.
For those missing values, we imputed the mean based on
those in the sample who answered the other questions in the
Decision Score the way they did.
Three items adapted from the Rose angina questionnaire
asked whether or not during the month before the stent
procedure respondents had any pain or discomfort in their
chest or arm when they: a) did strenuous exercise; b)
walked up stairs; c) walked one or two blocks on level
ground.22 This scale generated a symptom score of 0 to 3.
Those who reported pain on at least one item were given 0.5
for each other question they did not answer. We imputed the
overall mean for four respondents who did not answer any
questions.
The primary analysis consists of descriptive statistics,
presenting patient reports related to the decision making
process. Two regression models were run predicting the
Decision Process Score for each procedure separately that
used the demographic characteristics we measured and the
measured clinical covariates. STATA version 11 (Stata-
Corp, LP, College Station, TX) was used for the analysis.
RESULTS
Of the 800 sampled for prostate surgery, three were found to
be ineligible because they were deceased or lived in a
nursing home. Of the 797 believed to be eligible, 685
returned a survey, a response rate of 86%.
Of the 800 stent patients sampled, 22 were ineligible
because they had died, were in nursing homes, or because
they reported they had not had a stent procedure near the
date indicated in the claims. Of the 778 who were thought
to be eligible, 593 returned a questionnaire, a response rate
of 76%. Only 472 of those were included in this analysis for
reasons outlined above.
We compared respondents and nonrespondents with
respect to age, gender and race. There were no differences
for either sample with respect to age. Male stent patients
responded at a higher rate than females (p=0.02); white
prostate surgery patients responded at a higher rate than
nonwhites (<0.001).
The average time between the procedure and receipt of a
returned questionnaire was 14 months; that time did not
differ by procedure.
Table 1 displays the basic demographic and clinical
characteristics of the two samples. The prostate surgery
patients were considerably younger than the stent patients,
better educated, more likely to be married, and, of course,
they were all male, whereas 38% of the stent patients were
female. The self-rated health of the prostate surgery patients
was better as well.
Fifty-four percent of the stent patients reported that they
had had no arm or chest pain in the month preceding the
sampled stent procedure; 28 percent had had a CABG in the
past; 21 percent said they had had a heart attack at some
time in the past, although not within a week of the stent
procedure. Table 1 also presents the number of four co-
morbid conditions (diabetes, heart failure, stroke history or
COPD) reported by stent patients; these data were not
collected for prostate cancer patients.






No. (%) No. (%)
Age
65-70 342 (52) 114 (25)
71-75 258 (39) 135 (29)
> 76 63 (9) 212 (46)
Gender (Male) 685 (100) 294 (62)
Race (White) 588 (90) 419 (90)
Married/Partner 598 (88) 303 (65)
Education
HS Grad or less 217 (33) 240 (52)
Some college 181 (27) 111 (24)
College grad + 262 (40) 108 (24)
Self-rated Health
Excellent 166 (25) 23 (5)
Very Good 297 (45) 120 (26)
Good 158 (24) 197 (42)
Fair or Poor 43 (6) 124 (27)
Cancer Spread Outside Prostate 51 (8)
Angina Symptom Score
Zero 235 (54)
1 – 2 94 (22)
3 107 (24)
Had Previous Bypass Surgery 123 (28)






† The number reported can vary due to item non-response
‡ Comorbidities include diabetes, congestive heart failure, COPD, and
stroke
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Table 2 presents data on how patients reported they
interacted with physicians when making the decision to
have the interventions. Prostate cancer surgery patients
frequently (64%) reported that they were presented with at
least one alternative to surgery (brachytherapy, external
beam radiation or conservative management) to consider
seriously; a third of them said that no immediate active
treatment was presented as a serious option. Virtually all
(95%) reported discussing the reasons for surgery “a lot” or
“some”, while fewer (63%), but still a clear majority,
reported “a lot” or “some” discussion of reasons they might
not want surgery. Seventy-six percent said their physician
asked them what they wanted to do. Prostate cancer surgery
patients also were very likely (58%) to have gone on the
Internet for information and to report talking with more than
one doctor (67%) about the decision, although primary care
physicians were seldom (1%) cited as having major input.
The dynamics of decision making reported by stent
patients were quite different. Very few (10%) said they were
presented with any alternative approach (CABG or conser-
vative management) as a serious alternative to having a
stent; only six percent were offered conservative manage-
ment as a serious option. While most patients (77%)
reported discussing the reasons for the intervention “a lot”
or “some” with their physicians, only 19% said their
physicians discussed the reasons they might not want the
procedure “a lot” or “some”. Only 16% said that they were
asked about their own treatment preference. The picture of a
minimal decision making process was augmented by the
facts that only 14% of stent patients reported going on the
Internet for information and only 29% reported talking with
more than one physician about the decision. Like prostate
cancer surgery patients, stent patients seldom (3%) said a
primary care doctor had major input about the decision.
Linear regression models were run to predict the Decision
Process Scores for each procedure. The left-hand model in
Table 3 for prostate cancer surgery patients shows that there is
a significant tendency for patients with more education to
report a more substantive decision making process for
prostatectomy (p<0.001); whites (p=0.04) and those with
partners (p=0.02) also report a more extensive decision
making process. However, patient age, self-reported health
status, and evidence of cancer spread were unrelated to the
Decision Process Score, as was time between surgery and
completing the survey
For coronary artery disease, there may be a stronger case
for inserting a stent, and hence perhaps less shared decision
making, if the patient has severe angina or has had a
previous MI or CABG. The stent model in Table 3 shows
that patients who had a higher angina symptom score,
reported a more (not less) extensive shared decision making
process (p=0.002). No patient demographic characteristics
were significantly related to the decision-making process,
nor were any of the other measures of their health status or
histories, although those with a previous heart attack also
tended to report more discussion (p=0.07).
DISCUSSION
The recently published results from the DECISIONS survey
reported that patients were largely uninformed and unin-
volved in common decisions about long-term medication
Table 2. Discussion of Pros and Cons, Sources of Information, Alternatives Considered, and Patient Input
PCa Surgery (n=685)† Stent (n=472)†
n (%) n (%)
Exposure to information about decision
Doctors discussed “some” or “a lot” :
Reasons for surgery 625 (95) 341 (77)
Reasons might not want surgery 416 (63) 85 (19)
Patient went on Internet for information 394 (58) 61 (14)
Patient talked with 2 + doctors about decision 443 (67) 128 (29)
Patient talked most with specialist 550 (83) 399 (86)
Patient talked most with primary care physician 9 (1) 14 (3)
Alternative options considered
Doctor discussed watchful waiting (PCa) or
medication management (Stent) as a serious option
221 (34) 25 (6)
Doctor discussed an alternative§
intervention as a serious option
368 (57) 22 (5)
Doctor discussed any alternative§§
as a serious option
408 (64) 43 (10)
Patient’s views reflected in decision
Doctors asked about patient’s preference for treatment type 497 (76) 69 (16)
† The number reported can vary due to item non-response
§ Alternatives included radiation or brachytherapy for PCa Surgery patients and CABG surgery for stent patients
§§ Alternatives included radiation, brachytherapy, or watchful waiting for PCa surgery patients and CABG surgery or medication management for
stent patients
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and cancer screening, though they were somewhat more
involved in decisions about back surgery and hip and knee
replacement.20 When patients have options that deliver
similar benefits and entail different risks, as those in this
study did, they should have a thorough discussion of their
options before treatment decisions are made.
Prostate cancer surgery patients report considerable inter-
action with physicians around the surgical decision. Howev-
er, given the limited survival benefit provided by surgery, we
think that almost all surgical patients (not just 34%) should
be offered conservative management as a serious option,
particularly those over 70 and those in poor health. There
also was no evidence that those patients over 70 had a more
thorough decision making process than others.
Two recent papers report that elective stent patients
usually have the misperception that the procedure is
extending their lives, even when their physicians do not
share that perception.23,24 This study provides the explana-
tion: there is very little information sharing or discussion
with patients when stent procedures are done. It also
extends those findings from specific clinical settings to the
national Medicare population.
One possible reason for limited discussion is that many
stent procedures are done in conjunction with a diagnostic
angiogram, limiting the opportunities for discussion. A
possible reason those with angina symptoms report a better
decision process is that they may have been interacting with
physicians about possible options over a longer period of
time. However, given the frequency with which stents are
placed when angiograms are performed, we would argue
that a discussion of the potential decision to insert a stent
should be a routine part of the decision to perform a
diagnostic angiogram. Another explanation comes from
recent focus groups with cardiologists.25 While the cardiol-
ogists knew that existing clinical studies had found no
survival benefit for those with stable angina, many were still
convinced of the benefits of PCI, even for asymptomatic
patients.
Efforts to improve decision making should continue to
focus on increasing patient involvement, but we also think
increasing the involvement of primary care providers when
decisions are being made would be beneficial. Fewer than
three percent of respondents said their primary care provider
played a major role in their decisions. Because primary care
providers are likely to be less predisposed to a specific
treatment than specialists, they may provide more balanced
information and may increase the likelihood that conserva-
tive options are considered. In addition, there is evidence
that patients believe that important decisions are best carried
out with their primary care providers.26 As patient-centered
medical homes become robust centers for care coordination
it should become more common for patients to rely on that
setting for information and guidance when facing deci-
sions.27 The results also point to the potential value of
decision aids: routinely providing patients with unbiased,
balanced material in print, DVD or web-based form would
be a major step to ensure that patients know all the
reasonable options and the pros and cons of each.2,28
The study’s strengths are that data were collected from a
national probability sample of Medicare patients who
underwent these procedures and the response rates were
high. The major limitation is that the data come from patient
reports, which may imperfectly reflect the actual interac-
tions with physicians. Also, we surveyed only those who
had the procedures. It is possible that those who chose other
paths had a better decision making process. However, that
does not mitigate the ethical responsibility of providers to
inform and involve patients. These patients did get the
interventions, and many of them, including the majority of
stent patients, were not adequately informed or involved in
the decision.
Almost all patients considering prostate cancer surgery
should seriously consider radiotherapy and conservative
management. Although CABG is often not a reasonable
alternative for stent patients like those in this study, all stent
candidates with stable angina should seriously consider
Table 3. Regression Analysis of Decision Process Score
PCa Surgery Model (n=664) Stent Model (n=447)
β [95% CI] p β [95% CI] p
Intercept 2.13 [1.76,2.50] <0.001 0.91 [0.53,1.29] <0.001
Covariates
Age 0.06 [−0.07,0.18] 0.38 0.01 [−0.10,0.13] 0.83
Gender(Male) 0.07 [−0.12,0.27] 0.48
Race (White vs. Nonwhite) 0.28 [0.01,0.54] 0.04 0.02 [−0.27,0.31] 0.89
Education 0.21 [0.11,0.31] <0.001 0.04 [−0.07,0.15] 0.45
Married/Partner 0.29 [0.05,0.54] 0.02 0.10 [−0.10,0.30] 0.32
Self-rated Health 0.04 [−0.06,0.14] 0.45 −0.08 [−0.19,0.04] 0.18
Time from Procedure to Survey (Months) −0.01 [−0.06,0.04] 0.59 0.05 [−0.01,0.10] 0.11
PCa Surgery Covariates
Cancer Spread −0.05 [−0.35,0.25] 0.74
Stent Covariates
Angina Symptom Score 0.11 [0.04,0.18] 0.002
Had Previous Bypass 0.03 [−0.17,0.24] 0.76
Had Previous Heart Attack 0.20 [−0.02,0.41] 0.07
Total Comorbidities 0.07 [−0.04,0.19] 0.20
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conservative medical management. The implementation of
the PCMH should bring more involvement of primary care
physicians in decisions about interventions and increase the
likelihood that patients facing major decisions will under-
stand all their options and have their voices heard. The
routine use of decision aids would also increase patients’
information about options, though not necessarily their
involvement in decisions. Meanwhile, these data provide a
challenge and a baseline against which to measure the
progress that is very much needed.
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